Skip to main content
Signal8

ADAR1 Capital Management, LLC

SEC insider (Form 3/4/5 filer). CIK 0001940272. 10% Owner at InMed Pharmaceuticals Inc. (INM) and 4 other issuers. 73 reported Form 4/5 transactions since Sep 2024; latest on Oct 23, 2026. Located in AUSTIN, TX.

Companies ADAR1 Capital Management, LLC has filed insider reports for

  • InMed Pharmaceuticals Inc. (INM): 10% Owner
  • TENAX THERAPEUTICS, INC. (TENX): 10% Owner
  • NextCure, Inc. (NXTC): 10% Owner
  • Rallybio Corp (RLYB): 10% Owner
  • Keros Therapeutics, Inc. (KROS): 10% Owner
ADAR1 Capital Management, LLC profile photo

ADAR1 Capital Management, LLC

CIK: 0001940272

Transaction Breakdown

Open Market Buys (P)61 (83.6%)

High conviction signal

Open Market Sales (S)3 (4.1%)

Position reduction

Option Exercises (M)0 (0.0%)

Derivative conversions

Awards (A)0 (0.0%)

Compensation grants

Other (G, F, J, C, D, …)9 (12.3%)

Gifts, tax withholding, conversions, dispositions to the issuer and other codes

Companies & Roles (5)

InMed Pharmaceuticals Inc. logo
INM

InMed Pharmaceuticals Inc.

10% Owner
TENAX THERAPEUTICS, INC. logo
TENX

TENAX THERAPEUTICS, INC.

10% Owner
NextCure, Inc. logo
NXTC

NextCure, Inc.

10% Owner
Rallybio Corp logo
RLYB

Rallybio Corp

10% Owner
Keros Therapeutics, Inc. logo
KROS

Keros Therapeutics, Inc.

10% Owner

Discretionary Trading P&L

Holdings

Transaction History (73 total)

  • InMed Pharmaceuticals Inc. logo
    INM

    InMed Pharmaceuticals Inc.

    Oct 23, 2026
    Purchase
    Indirect
    4 shares at avg. $1.32$5.28
  • TENAX THERAPEUTICS, INC. logo
    TENX

    TENAX THERAPEUTICS, INC.

    Oct 21, 2026
    Purchase
    Indirect
    332K shares at avg. $1.66$551K
  • TENAX THERAPEUTICS, INC. logo
    TENX

    TENAX THERAPEUTICS, INC.

    Oct 20, 2026
    Purchase
    Indirect
    254.3K shares at avg. $1.60$406K
  • TENAX THERAPEUTICS, INC. logo
    TENX

    TENAX THERAPEUTICS, INC.

    Oct 19, 2026
    Purchase
    Indirect
    336.5K shares at avg. $1.51$507K
  • InMed Pharmaceuticals Inc. logo
    INM

    InMed Pharmaceuticals Inc.

    Oct 19, 2026
    Purchase
    Indirect
    1.1K shares at avg. $1.32$1K
  • InMed Pharmaceuticals Inc. logo
    INM

    InMed Pharmaceuticals Inc.

    Oct 16, 2026
    Purchase
    Indirect
    1 shares at avg. $1.32$1.32
  • InMed Pharmaceuticals Inc. logo
    INM

    InMed Pharmaceuticals Inc.

    Oct 15, 2026
    Purchase
    Indirect
    984 shares at avg. $1.32$1K
  • InMed Pharmaceuticals Inc. logo
    INM

    InMed Pharmaceuticals Inc.

    Oct 14, 2026
    Purchase
    Indirect
    8K shares at avg. $1.33$11K
  • InMed Pharmaceuticals Inc. logo
    INM

    InMed Pharmaceuticals Inc.

    Oct 13, 2026
    Purchase
    Indirect
    564 shares at avg. $1.33$750.12
  • InMed Pharmaceuticals Inc. logo
    INM

    InMed Pharmaceuticals Inc.

    Oct 8, 2026
    Purchase
    Indirect
    2.3K shares at avg. $1.33$3K

1-10 of 73

…